Monte Carlo PTA Simulation Guide
Monte Carlo PTA Simulation Guide
The Monte Carlo PTA (Probability of Target Attainment) simulator uses random sampling to predict how likely a dosing regimen will achieve a pharmacodynamic target across a patient population.
When to Use This Tool
- Evaluating antimicrobial dosing regimens
- Comparing dosing strategies across MIC distributions
- Supporting antibiotic stewardship decisions
- Generating data for clinical protocols and formulary decisions
Key Concepts
PK/PD Targets
Target: fT>MIC ≥ 40–70%
Used for: Penicillins, cephalosporins, carbapenems, aztreonam
The fraction of time the free drug concentration exceeds the MIC determines efficacy.
Target: Cmax/MIC ≥ 8–10
Used for: Gentamicin, tobramycin, amikacin
Peak concentration relative to MIC drives bacterial killing.
Target: AUC/MIC ≥ 400
Used for: Vancomycin, fluoroquinolones, linezolid, daptomycin
Total drug exposure over 24 hours relative to MIC predicts outcomes.
Input Parameters
| Parameter | Description |
|---|---|
| CL (mean, CV%) | Population clearance with variability |
| Vd (mean, CV%) | Volume of distribution with variability |
| Dose(s) | One or more doses to simulate |
| MIC(s) | One or more MIC values to test |
| Target index | fT>MIC, AUC/MIC, or Cmax/MIC |
| Target value | Numeric threshold |
| Protein binding | Free fraction (fu) |
| N simulations | Number of virtual patients (default: 5,000) |
Increasing N from 1,000 to 10,000 improves precision but extends computation time. For most clinical purposes, 5,000 simulations provide sufficient confidence.
Understanding Results
PTA Heatmap
The heatmap shows PTA (%) for each Dose × MIC combination:
| Color | PTA Range | Interpretation |
|---|---|---|
| 🟢 Dark green | ≥ 90% | Excellent — high probability of success |
| 🟡 Yellow | 70–89% | Moderate — may work for susceptible isolates |
| 🔴 Red | < 70% | Poor — consider alternative regimen |
PTA < 80% at the target MIC for your institution's susceptibility breakpoint suggests the regimen may be suboptimal. Consult your antimicrobial stewardship team.
Best Practices
Use local antibiogram data
Replace default MIC distributions with your institution's antibiogram whenever possible.
Simulate multiple regimens
Run at least 2–3 dosing strategies to compare (e.g., standard vs. extended infusion vs. continuous).
Consider special populations
Adjust CL and Vd for critically ill patients, burns, obesity, or augmented renal clearance.
Export for documentation
Download the simulation data (CSV) and heatmap for inclusion in stewardship reports.
Was this article helpful?